CO-INCIDENCE ABOUT THE FDA APPROVAL OF A COPY CAT DRUG WHILE THEN SELLING $10 MILLION SHARES, AFTER THE STOCK RALLIED TO MID $2 DOLLAR RANGE, EXERCISABLE AT $2 DOLLARS.
THAT'S WHAT THEY NEEDED TO DO BEFORE SELLING 10 MILLION SHARES THAT ARE EXERCISABLE AT $2 DOLLARS, NOW THE STOCK IS RETREATING TO $1.96 ON 06/12/09
Anyway, this approval is for a copy cat drug, and really is no big pay day for MRNA.
Everything else to do with MRNA is PRE-CLINICAL
The current (ROE) Return On Equity is -250.88%. This is a measure of managements effectiveness.
An indicator of a company's financial performance. It measures how efficient a company is with its money. The biggest stock market winners historically showed an ROE of 17% to 50% before they made their huge gains. Presented as a percentage figure, it is derived by dividing annual income (before extraordinary items, discontinued operations, cumulative accounting adjustments and non-recurring items) by an average of the latest fiscal year and the prior year's stockholders' equity
My opinion but I do not see why the hype is so warranted for a stock price above $1 dollar.
$1.91 (06/12/09)
